Incoming Admin May Shake Up Life Sciences Regulation, Law360

In a Law360 Expert Analysis column, partners Jaqueline Berman, Michele Buenafe, and Kathleen Sanzo discuss the potential regulatory shift toward drugs, devices, and other life sciences products from the incoming Trump-Vance Administration.

Read the full Law360 article >>